tiprankstipranks
Trending News
More News >
Neurones (FR:NRO)
:NRO
France Market

Neurones (NRO) Ratios

Compare
5 Followers

Neurones Ratios

FR:NRO's free cash flow for Q4 2024 was €0.48. For the 2024 fiscal year, FR:NRO's free cash flow was decreased by € and operating cash flow was €0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.33 2.38 2.45 2.51 2.78
Quick Ratio
2.33 2.38 2.44 2.51 2.77
Cash Ratio
1.29 1.30 0.37 0.52 0.89
Solvency Ratio
0.21 0.25 0.25 0.24 0.24
Operating Cash Flow Ratio
0.00 0.31 0.27 0.35 0.43
Short-Term Operating Cash Flow Coverage
0.00 12.35 361.43 315.53 260.34
Net Current Asset Value
€ 298.60M€ 279.47M€ 265.41M€ 249.22M€ 258.24M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.07 0.06 0.06 0.06
Debt-to-Equity Ratio
0.11 0.12 0.11 0.11 0.11
Debt-to-Capital Ratio
0.10 0.11 0.10 0.10 0.10
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.92 1.90 1.86 1.82 1.70
Debt Service Coverage Ratio
9.30 10.24 36.73 50.14 39.72
Interest Coverage Ratio
47.36 52.90 41.14 62.60 50.04
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
1.80 1.87 1.56 1.50 1.45
Net Debt to EBITDA
-3.31 -2.63 -0.46 -0.79 -1.59
Profitability Margins
Gross Profit Margin
62.47%46.78%12.27%12.03%13.08%
EBIT Margin
9.61%10.89%11.02%10.82%10.25%
EBITDA Margin
10.60%13.04%13.33%13.15%13.11%
Operating Profit Margin
9.61%10.23%10.66%10.43%9.73%
Pretax Profit Margin
10.87%10.90%10.76%10.43%10.05%
Net Profit Margin
6.48%6.67%6.65%6.50%5.89%
Continuous Operations Profit Margin
7.80%7.90%7.78%7.40%6.67%
Net Income Per EBT
59.59%61.18%61.80%62.36%58.63%
EBT Per EBIT
113.09%106.47%100.94%99.99%103.31%
Return on Assets (ROA)
7.23%7.33%7.17%6.64%5.62%
Return on Equity (ROE)
13.89%13.94%13.36%12.10%9.58%
Return on Capital Employed (ROCE)
16.47%17.03%17.29%15.78%13.14%
Return on Invested Capital (ROIC)
11.51%12.00%12.26%10.99%8.57%
Return on Tangible Assets
7.87%7.95%8.41%7.90%6.66%
Earnings Yield
4.92%4.73%4.65%4.10%5.45%
Efficiency Ratios
Receivables Turnover
3.74 3.57 2.97 3.52 3.01
Payables Turnover
5.21 8.96 13.60 13.52 13.96
Inventory Turnover
1.14K 556.30 590.24 333.65 348.80
Fixed Asset Turnover
13.39 12.62 13.36 12.58 11.24
Asset Turnover
1.12 1.10 1.08 1.02 0.95
Working Capital Turnover Ratio
2.48 2.41 2.30 2.04 1.93
Cash Conversion Cycle
27.98 62.10 96.63 77.73 96.24
Days of Sales Outstanding
97.65 102.20 122.85 103.63 121.34
Days of Inventory Outstanding
0.32 0.66 0.62 1.09 1.05
Days of Payables Outstanding
70.00 40.76 26.84 26.99 26.15
Operating Cycle
97.97 102.86 123.47 104.72 122.38
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 2.97 2.27 2.67 2.85
Free Cash Flow Per Share
0.00 2.23 1.83 2.40 2.55
CapEx Per Share
0.00 0.74 0.44 0.27 0.30
Free Cash Flow to Operating Cash Flow
0.00 0.75 0.81 0.90 0.90
Dividend Paid and CapEx Coverage Ratio
0.00 1.61 1.58 1.18 5.73
Capital Expenditure Coverage Ratio
0.00 4.01 5.18 9.83 9.59
Operating Cash Flow Coverage Ratio
0.00 1.64 1.52 1.83 2.02
Operating Cash Flow to Sales Ratio
0.00 0.10 0.08 0.11 0.13
Free Cash Flow Yield
0.00%5.18%4.66%6.31%10.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.32 21.14 21.49 24.40 18.35
Price-to-Sales (P/S) Ratio
1.32 1.41 1.43 1.59 1.08
Price-to-Book (P/B) Ratio
2.82 2.95 2.87 2.95 1.76
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 19.31 21.45 15.84 9.18
Price-to-Operating Cash Flow Ratio
0.00 14.49 17.31 14.23 8.22
Price-to-Earnings Growth (PEG) Ratio
2.95 1.93 1.24 1.12 23.30
Price-to-Fair Value
2.82 2.95 2.87 2.95 1.76
Enterprise Value Multiple
9.10 8.18 10.26 11.28 6.66
Enterprise Value
EV to EBITDA
9.10 8.18 10.26 11.28 6.66
EV to Sales
0.97 1.07 1.37 1.48 0.87
EV to Free Cash Flow
0.00 14.62 20.53 14.80 7.41
EV to Operating Cash Flow
0.00 10.97 16.57 13.29 6.64
Tangible Book Value Per Share
15.57 14.65 11.76 10.85 11.27
Shareholders’ Equity Per Share
15.58 14.62 13.67 12.87 13.31
Tax and Other Ratios
Effective Tax Rate
0.28 0.27 0.28 0.29 0.34
Revenue Per Share
33.39 30.58 27.47 23.95 21.64
Net Income Per Share
2.16 2.04 1.83 1.56 1.28
Tax Burden
0.60 0.61 0.62 0.62 0.59
Interest Burden
1.13 1.00 0.98 0.96 0.98
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.29 0.29
Stock-Based Compensation to Revenue
0.00 <0.01 <0.01 <0.01 <0.01
Income Quality
0.00 1.23 1.24 1.72 2.23
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis